BackMedTech Acquisition Overview
MedTech Acquisition Corp - Class A

MedTech Acquisition Debt to Equity

MedTech Acquisition (MTAC) has a debt-to-equity ratio of 49.55, above the sector sector average of 0.98.

Get informed when a big investor buys or sells

+ Follow

Debt to Equity

49.55

Debt to Equity

49.55

Debt-to-Equity ratio measures a company's financial leverage by comparing its total debt to shareholder equity. A lower D/E ratio generally indicates a more financially stable company with less risk.

Debt to Equity (Comparison Companies)

Loading

Debt to Equity History

Loading

Debt to Equity Comparison

Loading

MedTech Acquisition (MTAC) FAQ

MedTech Acquisition posts a debt-to-equity ratio of 49.55. That is above the sector sector average of 0.98. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

For its sector stocks, a debt-to-equity ratio near 0.98 is typical. MedTech Acquisition's 49.55 is higher that level. That is roughly 4959.6% above the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

MedTech Acquisition's debt-to-equity ratio of 49.55 comes from dividing a price-based measure by a related financial statistic. Changes can come from the stock price moving, the underlying fundamental shifting, or both. Track both the level and the trend — a rising multiple on falling fundamentals is a different story than a rising multiple on rising earnings.

Context for MTAC's debt-to-equity ratio usually means three checks: (1) trend versus prior periods, (2) level versus peers (average 0.98), and (3) consistency with growth and profitability. This page covers the first two; MedTech Acquisition's other metric pages and overview cover the third.